Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Assisted Reproductive Technology (ART) Market Size Worth USD 50.32 Billion by 2027 | CAGR of 9.3%: Emergen Research

This image opens in the lightbox

News provided by

Emergen Research

19 Oct, 2020, 12:35 GMT

Share this article

Share toX

Share this article

Share toX

- Growing awareness and social adoption of assisted reproductive technology are among the significant factors influencing the assisted reproductive technology market growth.

- Market Size – USD 24.62 Billion in 2019, Market Growth - CAGR of 9.3%, Market Trends –Surge in infertility rate

VANCOUVER, BC, Oct. 19, 2020 /PRNewswire/ -- The Global Assisted Reproductive Technology Market is projected to be worth USD 50.32 Billion by 2027, according to a new report by Emergen Research. The market for assisted reproductive technology (ART) is experiencing rapid growth attributed to the surging popularity of in-vitro fertilization (IVF) (with or without Intracytoplasmic Sperm Injection (ICSI)) and artificial insemination-intrauterine (AI-IUI), among other technologies. The growing prevalence of ovulation problems, a common cause of infertility in women with irregular or no periods, is a key factor boosting assisted reproductive technology market growth and accounts for around 25.0% of infertility cases in women across the globe.

A lack of awareness pertaining to fertility in people of the young generation and women opting for fertility treatments could increase fertility duration and, in due course, may need in-vitro fertilization, thereby fueling the demand for assisted reproductive technology. Infertility is a multi-faceted issue involving social, cultural, and economic implications, which may reach threatening extents in nations with having problems with demographics. According to statistics published by WHO, about 8.0-10.0% of couples are suffering from a certain type of infertility issue.

A significant cause of infertility in the worldwide population is sexually transmitted diseases (STDs), predominantly gonorrhea and chlamydia, which, in turn, would boost the growth of the assisted reproductive technology market. It may cause damage or scarring in the fallopian tubes and blockage and scarring of the reproductive structures (e.g., ejaculatory ducts), resulting in infertility.

Request free sample of this research report at: https://www.emergenresearch.com/request-sample/165

Key Highlights from The Report

  • In June 2020, Ferring Pharmaceuticals made an announcement about signing a two-year agreement with Igenomix for researching innovative disease mechanisms and target discovery in conditions associated with infertility and pregnancy, such as preeclampsia, for developing groundbreaking diagnostic and therapeutic approaches in catering to unmet demand.
  • Frozen non-donor eggs are projected to grow at the fastest rate in the period 2020-2027, owing to their established reliability and a higher success rate for pregnancy.
  • Artificial Insemination-Intrauterine doesn't require the removal of eggs from the body, and hence the procedure is far less invasive for the women who would conceive. Moreover, the process is cost-effective compared to IVF, as it doesn't require egg extraction/laboratory monitoring.
  • Factors such as well-resourced operating & surgical rooms, the presence of highly skilled healthcare professionals, higher purchasing power, and enhanced health coverage for healthcare services from various plans for private and group insurance, among others, are driving the demand for assisted reproductive technology in hospitals. However, a decreased adoption of the latest and innovative up-gradation is responsible for a lower market share.
  • Europe, led by France, Germany, and the U.K., contributed to the largest assisted reproductive technology market share in 2019 attributed to growing novelties in clinical practice and improved fertility treatment access in the region. Also, the region is the first to remove the 'experimental' tag on cryopreservation of eggs.
  • Key participants include Origio, Cryolab Ltd., Bloom IVF Center, Ferring Pharmaceuticals, Cosmos Biomedical, Irvine Scientific, European Sperm Bank, Ovascience, Parallabs, and Microm UK Ltd., among others.

To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/assistive-reproductive-technology-market

Emergen Research has segmented the Global Assisted Reproductive Technology (ART) Market on the basis of procedure, technology, end-user, and region:

Procedure Outlook (Revenue, USD Billion; 2017-2027)

  • Fresh Donor
  • Fresh Non-Donor
  • Frozen Donor
  • Frozen Non-Donor
  • Egg/Embryo Banking

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • In-Vitro Fertilization (IVF)
    1. In-Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI)
    2. In-Vitro Fertilization (IVF) without Intracytoplasmic Sperm Injection (ICSI)
  • Artificial Insemination-Intrauterine (AI-IUI)
  • Frozen Embryo Transfer (FET)
  • Others

Oder Now: https://www.emergenresearch.com/select-license/165

End-User Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals
  • Fertility Clinics
  • Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. U.K.
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

Find more similar research insights by Emergen Research:

Wound Cleanser Products Market By Product Type (Wetting Agents, Antiseptics, Moisturizers, Others), By Form Type (Sprays, Solutions, Wipes, Foams, Others), By End User (Hospitals, Ambulatory Surgery Centers, Pharmacies and Clinics, Homecare Settings) and By Regions Forecasts to 2027

Carrier Screening Market By Medical Conditions (Pulmonary, Hematological and Neurological Disorders, Others), By Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, Others), By End User (Hospitals, Reference Laboratories, Physician Offices and Clinics, Others) and By Regions Forecasts to 2027

Big Data in Healthcare Market By Component (Software, Services), By Deployment (On-Premises, Cloud), By Analytics Type (Predictive Analytics, Descriptive Analytics), By Application (Clinical Analytics, Financial Analytics), By End User (Hospitals and Clinics), and By Region, Forecasts to 2027

Photoacoustic Imaging Market By Product (Imaging Systems, Lasers, Transducers, Contrast Agents, Software), By Application (Oncology, Cardiology, Neurology, Hematology, Others), By End User (Research Institutions, Hospitals & Clinics) and By Regions Forecasts to 2027

Cancer Imaging Systems Market By Imaging Systems, By Application, By End-Users, Forecasts to 2027

About Emergen Research

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

With market-leading insights and an in-depth understanding of leading and niche technologies, our solutions address the most pertinent questions for your business needs. A major technological shift has been witnessed towards creating a 'Circular Economy,' fuelled by factors, such as the increased adoption of bio-based materials, along with other methods for achieving carbon neutrality. We are conversant in technologies, viz., Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT), Big Data Analytics, Machine learning, Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics, and Predictive Maintenance, among other prevalent and emergent technologies.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Read full Press Release at: https://www.emergenresearch.com/press-release/global-assisted-reproductive-technology-market

Logo: https://mma.prnewswire.com/media/1252126/Emergen_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.